Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation.
OBJECTIVE
Several epidemiologic studies have enhanced our understanding of the impact of respiratory viruses on bone marrow transplant recipients.


RESULTS
Respiratory viral infections occur frequently following stem cell transplantation but present atypically. Many patients have asymptomatic infections. There is a growing armamentarium of antiviral agents currently under development, although prospective studies in transplant patients are needed.


CONCLUSIONS
Respiratory viral infections occur frequently after hematopoietic stem cell transplant. Newer agents may prove useful in the prevention and treatment of respiratory viral infections in this population.
Ison
Michael G
MG
Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. mgison@northwestern.edu
D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006801:Humans; D018186:Pneumovirus Infections / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D011183:Postoperative Complications / Q000188:drug therapy; D018113:Respiratory Syncytial Virus, Human; D018108:Respirovirus
D000998:Antiviral Agents